With the recent launches of Novo Nordisk’s Wegovy pill and Eli Lilly’s Foundayo, the obesity market has started to shift toward oral GLP-1 drugs. While Novo leverages its first-mover advantage with ...
OpenAI said on Friday it cannot rule out that its upcoming AI model, Astra, has "critical" cybersecurity capabilities, prompting the startup to pause some internal development and trigger safety ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results